Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Small animal imaging in drug development.

Martin G Pomper1, Jae Sung Lee

  • 1Johns Hopkins University School of Medicine, Department of Radiology, MD, USA. mpomper@jhmi.edu

Current Pharmaceutical Design
|October 28, 2005
PubMed
Summary

Mapping human and mouse genomes advances disease understanding, enabling targeted cancer therapies. Molecular imaging in animal models is key for developing these novel, noninvasive treatments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Taxonomy, Host Associations, and Life Cycles of Four Rust Fungi Associated with <i>Prunus</i> spp. in Korea.

Mycobiology·2026
Same author

GPDM: generation-prior diffusion model for accelerated direct attenuation and scatter correction of whole-body18F-FDG PET.

Physics in medicine and biology·2026
Same author

First-in-Human Imaging Results of PHAROS: A Versatile High-Resolution TOF/DOI PET Scanner for Brain, Breast, and Extremity Imaging.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Same author

Influence of scintillation light confinement on depth-of-interaction measurement performance in a single-ended readout PET detector.

Physics in medicine and biology·2026
Same author

The hippocampal CA3 area implements sequence learning of discontinuous episodes.

Communications biology·2026
Same author

Metabolic neural networks of the marmoset brain in awake and isoflurane-anesthetized resting states.

Neuroscience·2026

Area of Science:

  • Genomics
  • Molecular Imaging
  • Translational Medicine

Background:

  • Genomic mapping offers new insights into disease mechanisms, shifting focus from organ systems to genetic defects.
  • This paradigm shift facilitates the development of more selective and less toxic therapies, particularly for genetically predisposed individuals.
  • Molecular imaging aims to noninvasively interrogate gene expression, playing a crucial role in advancing this therapeutic approach.

Purpose of the Study:

  • To highlight the impact of molecular imaging research on understanding and treating diseases like cancer.
  • To emphasize the importance of small animal models in bridging in vitro studies and human clinical imaging.
  • To underscore the value of noninvasive, quantitative imaging in evaluating new therapeutic strategies.

Main Methods:

  • Utilizing genomic data from human and mouse populations.
  • Employing molecular imaging techniques in small animal models.
  • Leveraging genetically modified animal models and advanced high-resolution imaging devices.

Main Results:

  • Improved mechanistic understanding of diseases, including cancer, through genome mapping.
  • Development of more targeted and potentially less toxic therapeutic strategies based on genetic predispositions.
  • Validation of molecular imaging as a critical tool for noninvasive gene expression interrogation.

Conclusions:

  • Genomic understanding and molecular imaging are revolutionizing disease treatment paradigms.
  • Small animal models are essential for preclinical evaluation of novel therapies.
  • Noninvasive imaging in genetically relevant models is crucial for advancing precision medicine.

Related Experiment Videos